Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival von ESCUDIER, Bernard, BELLMUNT, Joaquim, NEGRIER, Sylvie, BAJETTA, Emilio, MELICHAR, Bohuslav, BRACARDA, Sergio, RAVAUD, Alain, GOLDING, Sophie, JETHWA, Sangeeta, SNELLER, Vesna

Volltext

Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer von STOCKLER, Martin R, HILPERT, Felix, SORIO, Roberto, FREUDENSPRUNG, Ulrich, SNELLER, Vesna, HALES, Gill, PUJADE-LAURAINE, Eric, FRIEDLANDER, Michael, KING, Madeleine T, WENZEL, Lari, CHEE KHOON LEE, JOLY, Florence, DE GREGORIO, Nikolaus, ARRANZ, José Angel, MIRZA, Mansoor Raza

Volltext

TRLS-12. EFFICACY AND SAFETY OF ENTRECTINIB IN CHILDREN WITHNTRK ORROS1 FUSION-POSITIVE (FP) PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS von Bagchi, Aditi, Robinson, Giles W, Desai, Ami V, Wu, Yeming, Wang, Huanmin, Basu, Ellen M, Casanova, Michela, van Tilburg, Cornelis M, Campbell-Hewson, Quentin, Armstrong, Amy E, André, Nicolas, Devlin, Clare, Wulff, Jade, Cardenas, Alison, Hutchinson, Katherine E, Lian, Qinshu, Ryklansky, Carolina, Harmach, Vesna Sneller, Fox, Elizabeth, Gajjar, Amar

Volltext

Prediction of Progression-Free Survival Rates After Bevacizumab Plus Interferon Versus Interferon Alone in Patients with Metastatic Renal Cell Carcinoma: Comparison of a Nomogram t... von Karakiewicz, Pierre I, Sun, Maxine, Bellmunt, Joaquin, Sneller, Vesna, Escudier, Bernard

Volltext

Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon‐α2a and subsequent therapy with tyrosine kinase inhibitors: a r... von Bracarda, Sergio, Bellmunt, Joaquim, Melichar, Bohuslav, Négrier, Sylvie, Bajetta, Emilio, Ravaud, Alain, Sneller, Vesna, Escudier, Bernard

Volltext

Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer) von Gonzalez-Martin, Antonio, Gladieff, Laurence, Tholander, Bengt, Stroyakovsky, Daniel, Gore, Martin, Scambia, Giovanni, Oaknin, Ana, Sneller, Vesna, Freudensprung, Ulrich, Pignata, Sandro

Volltext

Health-related quality of life (HRQoL) results from the AURELIA trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum-resistant recurrent ovarian cancer (OC) von Stockler, Martin R., Hilpert, Felix, Friedlander, Michael, King, Madeleine, Wenzel, Lari B., Lee, Chee, Joly, Florence, De Gregorio, Nikolaus, Arranz Arija, Jose Angel, Mirza, Mansoor Raza, Sorio, Roberto, Freudensprung, Ulrich, Sneller, Vesna, Hales, Gill, Pujade Lauraine, Eric

Volltext